NASDAQ:FWP Forward Pharma A/S (FWP) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free FWP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.95▼$1.9550-Day Range$1.79▼$3.1952-Week Range$1.50▼$6.48VolumeN/AAverage Volume7,484 shsMarket Capitalization$13.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Forward Pharma A/S alerts: Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About Forward Pharma A/S Stock (NASDAQ:FWP)Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.Read More Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… FWP Stock News HeadlinesMay 17, 2024 | msn.comThese are the Waverly projects that will be paid for with $4.5 million from NY ForwardMay 2, 2024 | wsj.comFed Meeting Today: Interest-Rate Decision Looms; S&P 500 Futures Edge DownMay 1, 2024 | reuters.comFlamengo forward Barbosa cleared to play pending anti-doping ban appealApril 26, 2024 | msn.comMicrosoft marches forward with its plan to put more ads in the Windows 11 Start menuApril 26, 2024 | msn.comFidelity’s Timmer says S&P 500's forward P/E ratio drop amid recent selloff "good to see"April 10, 2024 | msn.comUK and Rwanda look forward to first migrant deportation flights in springApril 10, 2024 | msn.comWhere NATO Has An Enhanced Forward PresenceApril 4, 2024 | msn.comUbisoft Forward Date AnnouncedMarch 31, 2024 | msn.comMinnesota Wild forward could be facing second suspension of seasonMarch 30, 2024 | msn.comBridging Forward Program works to alleviate povertyMarch 29, 2024 | msn.comKeep Moving Forward: A Guide for Advancing your CareerMarch 28, 2024 | msn.comWhatsapp hits fast forward (and rewind) with a new video feature, rolling out to iOS and Android users very soonMarch 28, 2024 | msn.comDo Americans believe in karma? Here’s how many pay it forwardMarch 12, 2024 | msn.comTaking advantage of springing forwardMarch 11, 2024 | msn.comWhy spring forward: Wars, confusion and a hunger for sunlightMarch 11, 2024 | tmcnet.comForcepoint Awarded Frost & Sullivan's 2023 Global Company of the Year Award for Pioneering the Data Loss Prevention IndustryMarch 11, 2024 | msn.comDaylight saving time has begun. What to know about springing forwardFebruary 24, 2024 | news.yahoo.comBEST FOOT FORWARD | The progress to craft a legacyFebruary 24, 2024 | msn.comLightning Place Struggling Forward On WaiversFebruary 20, 2024 | yahoo.comTake a look at the approved final plans for Hanover's first WawaFebruary 19, 2024 | yahoo.comPaying It Forward: Go Beyond, Dream and Do!February 2, 2024 | msn.comPizzeria's pay-it-forward plan took off, then spread among Lansing Mall businessesJanuary 31, 2024 | msn.comHeartland's 60 Forward Center features bistro, duckpin bowling, hobby hubJanuary 31, 2024 | msn.comHistory suggests a strong year for the S&P 500 – CFRA’s Sam StovallJanuary 22, 2024 | businesswire.comPharma Logistics Appoints Healthcare Industry Veteran David A. Hargraves as CEO to Lead Next Phase of Growth; Founder, President & CEO Transitions to Board Member RoleSee More Headlines Receive FWP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/01/2016Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:FWP CUSIPN/A CIK1604924 Webwww.forward-pharma.com Phone(453) 344-4242FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio18.43 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.09 per share Price / Book0.19Miscellaneous Outstanding Shares7,091,000Free Float2,023,000Market Cap$13.83 million OptionableNot Optionable Beta1.38 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Florian Schonharting M.Sc. (Econ) (Age 53)Co-Founder & Chairman Dr. Claus Bo Søndergaard Svendsen M.D. (Age 45)Ph.D., Chief Exec. Officer Mr. Thomas Carbone (Age 65)VP of Fin. & Controller Key CompetitorsVaccinexNASDAQ:VCNXOnconova TherapeuticsNASDAQ:ONTXvTv TherapeuticsNASDAQ:VTVTBioLineRxNASDAQ:BLRXImmix BiopharmaNASDAQ:IMMXView All Competitors FWP Stock Analysis - Frequently Asked Questions How were Forward Pharma A/S's earnings last quarter? Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. What other stocks do shareholders of Forward Pharma A/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Celldex Therapeutics (CLDX), Catalyst Pharmaceuticals (CPRX), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Onconova Therapeutics (ONTX). This page (NASDAQ:FWP) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forward Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Forward Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.